Startseite No effect of MDR1 C3435T polymorphism on oral pharmacokinetics of telmisartan in 19 healthy Chinese male subjects
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

No effect of MDR1 C3435T polymorphism on oral pharmacokinetics of telmisartan in 19 healthy Chinese male subjects

  • Xin Guo , Xiao-Ping Chen , Ze-Neng Cheng , Xi Luo , Ren Guo , Lei Chen , Jie Chen , Bo Chen , Jun Peng und Yuan-Jian Li
Veröffentlicht/Copyright: 10. Dezember 2008
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background: Considerable interindividual differences in both drug response and pharmacokinetics of telmisartan have been identified. This study was designed to investigate the influence of MDR1 C3435T polymorphism on pharmacokinetics of telmisartan after a single oral dose in healthy Chinese volunteers.

Methods: A total of 61 unrelated male volunteers were genotyped for MDR1 C3435T polymorphism by using the polymerase chain reaction-restriction fragment length polymorphism method. Six 3435CC homozygotes, eight 3435CT heterozygotes, and five 3435TT homozygotes were randomly selected and received a single oral dose of 40 mg telmisartan. Plasma concentrations of telmisartan were determined by the high performance liquid chromatography-mass spectrometry method up to 48 h after telmisartan administration.

Results: Interindividual variation for tmax, Cmax, t1/2, AUC0–48, AUC0–∞, and clearance (CL) for telmisartan was approximately 6-, 33-, 16-, 17-, 20-, and 20-fold, respectively. Cmax (p=0.010), t1/2 (p=0.029) and CL (p=0.010) of telmisartan were not normally distributed. MDR1 3435TT homozygotes seemed to show increases in Cmax, tmax, t1/2, AUC0–48, and AUC0–∞. However, no significant differences in Cmax, tmax, t1/2, AUC0–48, AUC0–∞, and CL among MDR1 C3435T genotypes were observed.

Conclusions: MDR1 C3435T polymorphism does not affect oral pharmacokinetics of telmisartan.

Clin Chem Lab Med 2009;47:38–43.


a

Xin Guo and Xiao-Ping Chen contributed equally to this work.

Corresponding author: Professor Yuan-Jian Li, Department of Pharmacology, School of Pharmaceutical Science, Central South University, Changsha, Hunan 410008, China Phone: +86-731-2355078, Fax: +86-731-2355078,

Received: 2008-5-19
Accepted: 2008 -7-11
Published Online: 2008-12-10
Published Online: 2008-12-10
Published in Print: 2009-01-01

©2009 by Walter de Gruyter Berlin New York

Artikel in diesem Heft

  1. Reviews
  2. Molecular markers detecting circulating melanoma cells by reverse transcription polymerase chain reaction: methodological pitfalls and clinical relevance
  3. HIV-GB virus C co-infection: an overview
  4. Genetics and Molecular Diagnostics
  5. Relationships between C-reactive protein concentration and genotype in healthy volunteers
  6. SYBR Green-based real-time PCR assay for detection of VKORC1 and CYP2C9 polymorphisms that modulate warfarin dose requirement
  7. Functional polymorphisms in ACE and CYP11B2 genes and atrial fibrillation in patients with hypertensive heart disease
  8. No effect of MDR1 C3435T polymorphism on oral pharmacokinetics of telmisartan in 19 healthy Chinese male subjects
  9. A novel large deletion and three polymorphisms in the FECH gene associated with erythropoietic protoporphyria
  10. Aging and endothelial progenitor cell telomere length in healthy men
  11. Gln222Arg (A2317G) polymorphism in the deoxyribonuclease I gene exhibits ethnic and functional differences
  12. Mutation screening of the medium-chain acyl-CoA dehydrogenase (MCAD) and the ornithine transcarbamylase (OTC) genes by multiplex PCR amplification and sequencing
  13. General Clinical Chemistry and Laboratory Medicine
  14. Nitrated apolipoprotein A-I, a potential new cardiovascular marker, is markedly increased in low high-density lipoprotein cholesterol subjects
  15. Relationships of serum haptoglobin concentration with HbA1c and glycated albumin concentrations in Japanese type 2 diabetic patients
  16. Multi-elements (aluminium, copper, magnesium, manganese, selenium and zinc) determination in serum by dynamic reaction cell-inductively coupled plasma-mass spectrometry
  17. Urinary neutrophil gelatinase-associated lipocalin (NGAL) as an early marker of acute kidney injury in critically ill multiple trauma patients
  18. Validation and Outcome Studies
  19. Validation for quantification of immunoglobulins by Fourier transform infrared spectrometry
  20. Albumin-based or albumin-linked calibrators cause a positive bias in serum proteins assayed by the biuret method
  21. Current practices in antinuclear antibody testing: results from the Belgian External Quality Assessment Scheme
  22. Verification of the analytical range of a new reagent for full-range C-reactive protein determination
  23. Measurement uncertainty in manual differential leukocyte counting
  24. Letters to the Editor
  25. Falsely elevated carbohydrate antigen 19-9 level due to heterophilic antibody interference but not rheumatoid factor: a case report
  26. An unusual interference in parathormone assay caused by anti-goat IgG: a case report
Heruntergeladen am 10.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2009.019/html
Button zum nach oben scrollen